As of September 2026 BridgeBio Oncology Therapeutics has a market cap of $0.54 Billion USD. This makes BridgeBio Oncology Therapeutics the world's 7550th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.